taurolidine

DRUG6 trials

Conditions

Brain and Central Nervous System TumorsCardiac Implantable Electronic Device InfectionCatheter-Related InfectionsFallopian Tube CancerInfectionOvarian CancerParenteral NutritionPrimary Peritoneal Cavity Cancer

Phase 1

Taurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

CompletedNCT00021034

Memorial Sloan Kettering Cancer CenterFallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer

Start: 2001-03-31End: 2001-08-31Updated: 2013-06-18

Taurolidine in Treating Patients With Recurrent or Progressive Glioma

CompletedNCT00022360

Memorial Sloan Kettering Cancer CenterBrain and Central Nervous System Tumors

Start: 2001-05-31End: 2001-10-31Updated: 2013-06-18

Phase 3

The AOT (Acridine Orange and Taurolidine) Trial

CompletedNCT00321165

Radboud University Medical CenterInfection, Parenteral Nutrition, Sepsis

Start: 2006-06-30End: 2008-03-31Target: 60Updated: 2009-02-11

Phase 4

Heparin Versus Taurolidine to Bloodstream Infection Prevention Related in Central Venous Catheter in Children

NCT02515201

Hospital de Clinicas de Porto AlegreCatheter-Related Infections

Start: 2014-09-30End: 2016-12-31Target: 20Updated: 2015-08-04

Unknown Phase

Effect of Taurolidin on Prevention of Bloodstream Infection

TerminatedNCT00545831

University Hospital, RouenSepsis

Start: 2007-10-31End: 2011-12-31Updated: 2013-03-05

Taurolidine Containing Antimicrobial CIED Wash to Prevent Infection

CompletedNCT05576194

Prof. Dr. Hendrik BonnemeierCardiac Implantable Electronic Device Infection

Start: 2020-01-01End: 2022-09-01Updated: 2023-12-06

Related Papers

Use of a taurolidine containing antimicrobial wash to reduce cardiac implantable electronic device infection

EP Europace2023-10-0121 citations

Taurolidine Lock vs Heparin Lock in Children and Adolescents on Chronic Parenteral Nutrition

Transplantation2017-06-011 citations